Farzad Alemi
- Gastroenterology top 5%
- Gastrointestinal motility and disorders 3
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 7
- Drug Transport and Resistance Mechanisms 3
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Dermatology top 10%
-
- Neuroendocrine Tumor Research Advances 3
-
- Renal cell carcinoma treatment 2
- Gallbladder and Bile Duct Disorders 2
- Co-authors
- Carlos U. CorveraDaniel P. PooleNigel W. BunnettKristina SchoonjansFiore CattaruzzaJonathan ChiuJohn R. GriderGraeme S. Cottrell
- Cited by
- GastroenterologyHepatologyOncology
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)Gastroenterology (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Farzad Alemi
15 papers receiving 796 citations
Peers
Comparison fields: 5 of 74
- Gastroenterology 152
- Hepatology 126
- Oncology 359
- Surgery 341
- Dermatology 60
Countries citing papers authored by Farzad Alemi
This map shows the geographic impact of Farzad Alemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzad Alemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzad Alemi more than expected).
Fields of papers citing papers by Farzad Alemi
This network shows the impact of papers produced by Farzad Alemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzad Alemi. The network helps show where Farzad Alemi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Farzad Alemi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | 2019 | 57 | |
| 3 | 2016 | 13 | |
| 4 | 2016 | 1 | |
| 5 | 2016 | 31 | |
| 6 | 2015 | 3 | |
| 7 | 2015 | 7 | |
| 8 | 2014 | 1 | |
| 9 | 2013 | 71 | |
| 10 | 2013 | 300 | |
| 11 | 2012 | 279 | |
| 12 | 2012 | 29 | |
| 13 | 2012 | 1 | |
| 14 | 2011 | 8 | |
| 15 | 2010 | 12 |
About Farzad Alemi
Farzad Alemi is a scholar working on Gastroenterology, Oncology and Hepatology, having authored 15 papers that have together received 814 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Gastrointestinal motility and disorders (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Renal cell carcinoma treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Gallbladder and Bile Duct Disorders (2 papers). The work is most often cited by research in Gastroenterology (152 citations), Hepatology (126 citations) and Oncology (359 citations). Farzad Alemi has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Carlos U. Corvera, Daniel P. Poole, Nigel W. Bunnett, Kristina Schoonjans, Fiore Cattaruzza, Jonathan Chiu, John R. Grider, Graeme S. Cottrell, Edwin Kwon and Subhashini Ayloo. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.